nodes	percent_of_prediction	percent_of_DWPC	metapath
Rocuronium—HTR3A—fourth ventricle—malignant glioma	0.407	0.452	CbGeAlD
Rocuronium—Pipecuronium—BCHE—malignant glioma	0.0419	0.525	CrCbGaD
Rocuronium—Pancuronium—BCHE—malignant glioma	0.0379	0.475	CrCbGaD
Rocuronium—HTR3A—brainstem—malignant glioma	0.0319	0.0355	CbGeAlD
Rocuronium—CHRNB1—medulla oblongata—malignant glioma	0.0289	0.0322	CbGeAlD
Rocuronium—HTR3A—telencephalon—malignant glioma	0.0283	0.0315	CbGeAlD
Rocuronium—CHRNB1—midbrain—malignant glioma	0.0265	0.0294	CbGeAlD
Rocuronium—CHRNB1—spinal cord—malignant glioma	0.0258	0.0287	CbGeAlD
Rocuronium—CHRM2—telencephalon—malignant glioma	0.0236	0.0263	CbGeAlD
Rocuronium—SLC22A1—telencephalon—malignant glioma	0.0232	0.0258	CbGeAlD
Rocuronium—CHRNA2—central nervous system—malignant glioma	0.0225	0.025	CbGeAlD
Rocuronium—SLCO1A2—telencephalon—malignant glioma	0.0223	0.0248	CbGeAlD
Rocuronium—CHRNA2—cerebellum—malignant glioma	0.022	0.0245	CbGeAlD
Rocuronium—CHRNA1—brain—malignant glioma	0.0215	0.0239	CbGeAlD
Rocuronium—CHRNB1—cerebellum—malignant glioma	0.0205	0.0228	CbGeAlD
Rocuronium—CHRNA2—brain—malignant glioma	0.0179	0.0199	CbGeAlD
Rocuronium—SLCO1A2—medulla oblongata—malignant glioma	0.0175	0.0195	CbGeAlD
Rocuronium—CHRNB1—brain—malignant glioma	0.0166	0.0185	CbGeAlD
Rocuronium—HTR3A—central nervous system—malignant glioma	0.0161	0.0179	CbGeAlD
Rocuronium—SLCO1A2—midbrain—malignant glioma	0.016	0.0178	CbGeAlD
Rocuronium—SLCO1A2—spinal cord—malignant glioma	0.0156	0.0174	CbGeAlD
Rocuronium—CHRM2—central nervous system—malignant glioma	0.0134	0.0149	CbGeAlD
Rocuronium—SLC22A1—central nervous system—malignant glioma	0.0132	0.0147	CbGeAlD
Rocuronium—HTR3A—brain—malignant glioma	0.0128	0.0142	CbGeAlD
Rocuronium—SLCO1A2—central nervous system—malignant glioma	0.0127	0.0141	CbGeAlD
Rocuronium—SLCO1A2—cerebellum—malignant glioma	0.0124	0.0138	CbGeAlD
Rocuronium—CHRM2—brain—malignant glioma	0.0107	0.0118	CbGeAlD
Rocuronium—SLC22A1—brain—malignant glioma	0.0105	0.0116	CbGeAlD
Rocuronium—SLCO1A2—brain—malignant glioma	0.0101	0.0112	CbGeAlD
Rocuronium—HTR3A—Transmembrane transport of small molecules—TFRC—malignant glioma	8.16e-05	0.00386	CbGpPWpGaD
Rocuronium—SLCO1A2—SLC-mediated transmembrane transport—SLC5A5—malignant glioma	8.14e-05	0.00385	CbGpPWpGaD
Rocuronium—CHRM2—GPCRs, Class A Rhodopsin-like—CCR4—malignant glioma	7.86e-05	0.00372	CbGpPWpGaD
Rocuronium—CHRND—Neuronal System—BRAF—malignant glioma	7.82e-05	0.0037	CbGpPWpGaD
Rocuronium—SLCO1A2—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	7.75e-05	0.00367	CbGpPWpGaD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—FTH1—malignant glioma	7.56e-05	0.00358	CbGpPWpGaD
Rocuronium—HTR3A—Transmembrane transport of small molecules—SLC5A5—malignant glioma	7.49e-05	0.00355	CbGpPWpGaD
Rocuronium—SLC22A1—Transmission across Chemical Synapses—BCHE—malignant glioma	7.42e-05	0.00351	CbGpPWpGaD
Rocuronium—HTR3A—SIDS Susceptibility Pathways—VEGFA—malignant glioma	7.29e-05	0.00345	CbGpPWpGaD
Rocuronium—CHRNA1—Transmission across Chemical Synapses—MDM2—malignant glioma	7.27e-05	0.00344	CbGpPWpGaD
Rocuronium—CHRNA1—Transmission across Chemical Synapses—RAF1—malignant glioma	7.25e-05	0.00343	CbGpPWpGaD
Rocuronium—CHRM2—Calcium Regulation in the Cardiac Cell—GJA1—malignant glioma	7.25e-05	0.00343	CbGpPWpGaD
Rocuronium—HTR3A—Transmembrane transport of small molecules—SLC6A3—malignant glioma	7.13e-05	0.00338	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—GJA1—malignant glioma	6.98e-05	0.00331	CbGpPWpGaD
Rocuronium—SLC22A1—Transmission across Chemical Synapses—SLC6A3—malignant glioma	6.98e-05	0.0033	CbGpPWpGaD
Rocuronium—CHRNA2—Transmission across Chemical Synapses—MDM2—malignant glioma	6.91e-05	0.00327	CbGpPWpGaD
Rocuronium—CHRNA2—Transmission across Chemical Synapses—RAF1—malignant glioma	6.89e-05	0.00326	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—RTEL1—malignant glioma	6.74e-05	0.00319	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR4—malignant glioma	6.73e-05	0.00319	CbGpPWpGaD
Rocuronium—CHRNA1—Neuronal System—BRAF—malignant glioma	6.65e-05	0.00315	CbGpPWpGaD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—ATP1B2—malignant glioma	6.6e-05	0.00313	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	6.59e-05	0.00312	CbGpPWpGaD
Rocuronium—CHRND—Neuronal System—MDM2—malignant glioma	6.55e-05	0.0031	CbGpPWpGaD
Rocuronium—CHRND—Neuronal System—RAF1—malignant glioma	6.53e-05	0.00309	CbGpPWpGaD
Rocuronium—CHRM2—Regulation of Actin Cytoskeleton—PTK2—malignant glioma	6.43e-05	0.00305	CbGpPWpGaD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—APOD—malignant glioma	6.42e-05	0.00304	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	6.38e-05	0.00302	CbGpPWpGaD
Rocuronium—CHRNA2—Neuronal System—BRAF—malignant glioma	6.32e-05	0.00299	CbGpPWpGaD
Rocuronium—CHRM2—G alpha (i) signalling events—CXCR3—malignant glioma	6.3e-05	0.00298	CbGpPWpGaD
Rocuronium—HTR3A—SIDS Susceptibility Pathways—TNF—malignant glioma	6.25e-05	0.00296	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—HES1—malignant glioma	6.09e-05	0.00288	CbGpPWpGaD
Rocuronium—CHRM2—Regulation of Actin Cytoskeleton—PDGFRA—malignant glioma	6.02e-05	0.00285	CbGpPWpGaD
Rocuronium—SLC22A1—SLC-mediated transmembrane transport—SLC5A5—malignant glioma	5.94e-05	0.00281	CbGpPWpGaD
Rocuronium—CHRM2—GPCRs, Class A Rhodopsin-like—CXCR3—malignant glioma	5.84e-05	0.00277	CbGpPWpGaD
Rocuronium—CHRM2—G alpha (i) signalling events—BDKRB2—malignant glioma	5.76e-05	0.00273	CbGpPWpGaD
Rocuronium—SLC22A1—Neuronal System—BCHE—malignant glioma	5.69e-05	0.00269	CbGpPWpGaD
Rocuronium—SLC22A1—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	5.66e-05	0.00268	CbGpPWpGaD
Rocuronium—CHRNA1—Neuronal System—MDM2—malignant glioma	5.57e-05	0.00264	CbGpPWpGaD
Rocuronium—CHRNA1—Neuronal System—RAF1—malignant glioma	5.55e-05	0.00263	CbGpPWpGaD
Rocuronium—CHRM2—Regulation of Actin Cytoskeleton—PDGFB—malignant glioma	5.4e-05	0.00256	CbGpPWpGaD
Rocuronium—CHRM2—Regulation of Actin Cytoskeleton—FGFR1—malignant glioma	5.38e-05	0.00255	CbGpPWpGaD
Rocuronium—SLC22A1—Neuronal System—SLC6A3—malignant glioma	5.35e-05	0.00253	CbGpPWpGaD
Rocuronium—CHRM2—GPCRs, Class A Rhodopsin-like—BDKRB2—malignant glioma	5.34e-05	0.00253	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—COX8A—malignant glioma	5.3e-05	0.00251	CbGpPWpGaD
Rocuronium—CHRNA2—Neuronal System—MDM2—malignant glioma	5.29e-05	0.00251	CbGpPWpGaD
Rocuronium—CHRNA2—Neuronal System—RAF1—malignant glioma	5.28e-05	0.0025	CbGpPWpGaD
Rocuronium—CHRM2—G alpha (i) signalling events—KNG1—malignant glioma	5.24e-05	0.00248	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—CCR4—malignant glioma	5.13e-05	0.00243	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—HIF1A—malignant glioma	5.1e-05	0.00242	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCR3—malignant glioma	5.01e-05	0.00237	CbGpPWpGaD
Rocuronium—CHRM2—Regulation of Actin Cytoskeleton—F2—malignant glioma	4.87e-05	0.00231	CbGpPWpGaD
Rocuronium—CHRM2—Regulation of Actin Cytoskeleton—FN1—malignant glioma	4.87e-05	0.00231	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	4.74e-05	0.00224	CbGpPWpGaD
Rocuronium—CHRM2—Regulation of Actin Cytoskeleton—APC—malignant glioma	4.67e-05	0.00221	CbGpPWpGaD
Rocuronium—CHRM2—Regulation of Actin Cytoskeleton—PIK3CG—malignant glioma	4.67e-05	0.00221	CbGpPWpGaD
Rocuronium—CHRM2—Regulation of Actin Cytoskeleton—EGF—malignant glioma	4.61e-05	0.00218	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—BDKRB2—malignant glioma	4.58e-05	0.00217	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—ASMT—malignant glioma	4.5e-05	0.00213	CbGpPWpGaD
Rocuronium—SLCO1A2—Transmembrane transport of small molecules—TFRC—malignant glioma	4.5e-05	0.00213	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	4.4e-05	0.00208	CbGpPWpGaD
Rocuronium—CHRM2—Regulation of Actin Cytoskeleton—BRAF—malignant glioma	4.39e-05	0.00208	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—LATS2—malignant glioma	4.38e-05	0.00207	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—BCAN—malignant glioma	4.24e-05	0.00201	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—KNG1—malignant glioma	4.16e-05	0.00197	CbGpPWpGaD
Rocuronium—SLCO1A2—Transmembrane transport of small molecules—SLC5A5—malignant glioma	4.14e-05	0.00196	CbGpPWpGaD
Rocuronium—CHRM2—Regulation of Actin Cytoskeleton—PIK3CD—malignant glioma	4.1e-05	0.00194	CbGpPWpGaD
Rocuronium—SLCO1A2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	3.94e-05	0.00186	CbGpPWpGaD
Rocuronium—CHRM2—Regulation of Actin Cytoskeleton—FGF2—malignant glioma	3.93e-05	0.00186	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—COX8A—malignant glioma	3.87e-05	0.00183	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—CXCR3—malignant glioma	3.81e-05	0.00181	CbGpPWpGaD
Rocuronium—SLC22A1—Transmission across Chemical Synapses—BRAF—malignant glioma	3.79e-05	0.00179	CbGpPWpGaD
Rocuronium—CHRM2—Regulation of Actin Cytoskeleton—RAF1—malignant glioma	3.66e-05	0.00173	CbGpPWpGaD
Rocuronium—CHRM2—Regulation of Actin Cytoskeleton—PIK3CB—malignant glioma	3.57e-05	0.00169	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—BDKRB2—malignant glioma	3.49e-05	0.00165	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—IDH2—malignant glioma	3.41e-05	0.00162	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—LATS1—malignant glioma	3.32e-05	0.00157	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—CXCL8—malignant glioma	3.31e-05	0.00157	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—ASMT—malignant glioma	3.29e-05	0.00156	CbGpPWpGaD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—TFRC—malignant glioma	3.29e-05	0.00156	CbGpPWpGaD
Rocuronium—HTR3A—Transmembrane transport of small molecules—RAF1—malignant glioma	3.23e-05	0.00153	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	3.22e-05	0.00152	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—CYP2B6—malignant glioma	3.21e-05	0.00152	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—IL1B—malignant glioma	3.18e-05	0.0015	CbGpPWpGaD
Rocuronium—SLC22A1—Transmission across Chemical Synapses—MDM2—malignant glioma	3.17e-05	0.0015	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—KNG1—malignant glioma	3.17e-05	0.0015	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—CASP3—malignant glioma	3.17e-05	0.0015	CbGpPWpGaD
Rocuronium—SLC22A1—Transmission across Chemical Synapses—RAF1—malignant glioma	3.16e-05	0.0015	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—BCAN—malignant glioma	3.09e-05	0.00146	CbGpPWpGaD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	3.02e-05	0.00143	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—IDH1—malignant glioma	2.94e-05	0.00139	CbGpPWpGaD
Rocuronium—SLC22A1—Neuronal System—BRAF—malignant glioma	2.9e-05	0.00137	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—CCR4—malignant glioma	2.9e-05	0.00137	CbGpPWpGaD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	2.87e-05	0.00136	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—SPHK1—malignant glioma	2.84e-05	0.00135	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—CYP2C18—malignant glioma	2.78e-05	0.00132	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—F2—malignant glioma	2.69e-05	0.00127	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—VEGFA—malignant glioma	2.69e-05	0.00127	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—CCR4—malignant glioma	2.63e-05	0.00125	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.62e-05	0.00124	CbGpPWpGaD
Rocuronium—CHRM2—Regulation of Actin Cytoskeleton—EGFR—malignant glioma	2.51e-05	0.00119	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—IDH2—malignant glioma	2.49e-05	0.00118	CbGpPWpGaD
Rocuronium—SLC22A1—Neuronal System—MDM2—malignant glioma	2.43e-05	0.00115	CbGpPWpGaD
Rocuronium—SLC22A1—Neuronal System—RAF1—malignant glioma	2.42e-05	0.00115	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.39e-05	0.00113	CbGpPWpGaD
Rocuronium—CHRM2—G alpha (i) signalling events—CXCL8—malignant glioma	2.39e-05	0.00113	CbGpPWpGaD
Rocuronium—CHRM2—Regulation of Actin Cytoskeleton—KRAS—malignant glioma	2.37e-05	0.00112	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—CYP2B6—malignant glioma	2.34e-05	0.00111	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.31e-05	0.00109	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—TNF—malignant glioma	2.3e-05	0.00109	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—GSTT1—malignant glioma	2.25e-05	0.00107	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—MDK—malignant glioma	2.24e-05	0.00106	CbGpPWpGaD
Rocuronium—CHRM2—Regulation of Actin Cytoskeleton—PIK3CA—malignant glioma	2.18e-05	0.00103	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—CXCR3—malignant glioma	2.15e-05	0.00102	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—IDH1—malignant glioma	2.14e-05	0.00102	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—DTX1—malignant glioma	2.14e-05	0.00101	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—PTGS1—malignant glioma	2.11e-05	0.000999	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.1e-05	0.000995	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—SPHK1—malignant glioma	2.07e-05	0.000983	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—F2—malignant glioma	2.05e-05	0.000971	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—CYP2C18—malignant glioma	2.03e-05	0.000963	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—BDKRB2—malignant glioma	1.97e-05	0.000933	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—BCHE—malignant glioma	1.96e-05	0.000929	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—CXCR3—malignant glioma	1.96e-05	0.000926	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—SLC5A5—malignant glioma	1.94e-05	0.000917	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—malignant glioma	1.9e-05	0.000898	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.83e-05	0.000867	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.81e-05	0.000859	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—KNG1—malignant glioma	1.79e-05	0.000849	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—BDKRB2—malignant glioma	1.79e-05	0.000847	CbGpPWpGaD
Rocuronium—SLCO1A2—Transmembrane transport of small molecules—RAF1—malignant glioma	1.78e-05	0.000845	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—SUFU—malignant glioma	1.7e-05	0.000805	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—HEY2—malignant glioma	1.68e-05	0.000795	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—GSTT1—malignant glioma	1.64e-05	0.000778	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—GFAP—malignant glioma	1.64e-05	0.000777	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—KNG1—malignant glioma	1.63e-05	0.000771	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—SPHK1—malignant glioma	1.59e-05	0.000752	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.58e-05	0.000749	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—GSTP1—malignant glioma	1.56e-05	0.000739	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CCR4—malignant glioma	1.55e-05	0.000736	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—HEY1—malignant glioma	1.55e-05	0.000736	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—PTGS1—malignant glioma	1.54e-05	0.000729	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—CAT—malignant glioma	1.52e-05	0.000719	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—HIST1H3B—malignant glioma	1.51e-05	0.000715	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—CXCL8—malignant glioma	1.44e-05	0.000684	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—MMP3—malignant glioma	1.44e-05	0.000683	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—NCOR1—malignant glioma	1.43e-05	0.000679	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—BCHE—malignant glioma	1.43e-05	0.000678	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—SLC5A5—malignant glioma	1.41e-05	0.00067	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—JAG2—malignant glioma	1.38e-05	0.000653	CbGpPWpGaD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—RAF1—malignant glioma	1.3e-05	0.000617	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—CAV1—malignant glioma	1.17e-05	0.000553	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—H3F3A—malignant glioma	1.17e-05	0.000552	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—F2—malignant glioma	1.16e-05	0.000549	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CXCR3—malignant glioma	1.16e-05	0.000547	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—GSTP1—malignant glioma	1.14e-05	0.00054	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—NTRK2—malignant glioma	1.12e-05	0.000532	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—YWHAE—malignant glioma	1.12e-05	0.000532	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—FLT1—malignant glioma	1.12e-05	0.00053	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.12e-05	0.000529	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—DUSP6—malignant glioma	1.11e-05	0.000528	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—CAT—malignant glioma	1.11e-05	0.000525	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—PIK3CG—malignant glioma	1.11e-05	0.000525	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—JAG1—malignant glioma	1.1e-05	0.000521	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—NOTCH3—malignant glioma	1.1e-05	0.000519	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—FBXW7—malignant glioma	1.08e-05	0.00051	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—PIK3CG—malignant glioma	1.06e-05	0.000504	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—BDKRB2—malignant glioma	1.06e-05	0.0005	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—F2—malignant glioma	1.05e-05	0.000498	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—NCOR1—malignant glioma	1.05e-05	0.000496	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—PPARG—malignant glioma	1.03e-05	0.000487	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—AKT2—malignant glioma	1.01e-05	0.00048	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—PIK3CG—malignant glioma	1.01e-05	0.000477	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—PTPN11—malignant glioma	9.89e-06	0.000468	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—NOTCH2—malignant glioma	9.83e-06	0.000465	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—PIK3CD—malignant glioma	9.75e-06	0.000462	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—KNG1—malignant glioma	9.61e-06	0.000455	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—PIK3CD—malignant glioma	9.36e-06	0.000443	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—AKT2—malignant glioma	9.21e-06	0.000436	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—NTRK1—malignant glioma	9.16e-06	0.000434	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—PIK3CD—malignant glioma	8.85e-06	0.000419	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—CAV1—malignant glioma	8.54e-06	0.000404	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—MMP3—malignant glioma	8.52e-06	0.000403	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—PIK3CB—malignant glioma	8.49e-06	0.000402	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CDKN2B—malignant glioma	8.44e-06	0.0004	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PTK2—malignant glioma	8.2e-06	0.000388	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—CXCL8—malignant glioma	8.16e-06	0.000387	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—PIK3CB—malignant glioma	8.16e-06	0.000386	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—PTGS2—malignant glioma	8.08e-06	0.000383	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—HES1—malignant glioma	8.06e-06	0.000381	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—NCOR1—malignant glioma	8.01e-06	0.000379	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—RAF1—malignant glioma	7.9e-06	0.000374	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—IL2—malignant glioma	7.8e-06	0.000369	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—PIK3CG—malignant glioma	7.78e-06	0.000368	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—PIK3CB—malignant glioma	7.71e-06	0.000365	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PDGFRA—malignant glioma	7.67e-06	0.000363	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—PPARG—malignant glioma	7.5e-06	0.000355	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—SPP1—malignant glioma	7.45e-06	0.000353	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—CXCL8—malignant glioma	7.41e-06	0.000351	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—IL2—malignant glioma	7.08e-06	0.000335	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—TERT—malignant glioma	7.06e-06	0.000334	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—PTEN—malignant glioma	7.05e-06	0.000334	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PDGFB—malignant glioma	6.89e-06	0.000326	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—FGFR1—malignant glioma	6.85e-06	0.000325	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—PIK3CD—malignant glioma	6.84e-06	0.000324	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—HIF1A—malignant glioma	6.75e-06	0.00032	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CAV1—malignant glioma	6.53e-06	0.000309	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—KDR—malignant glioma	6.46e-06	0.000306	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—F2—malignant glioma	6.21e-06	0.000294	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—FN1—malignant glioma	6.21e-06	0.000294	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—BAD—malignant glioma	6.14e-06	0.000291	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—NOTCH1—malignant glioma	6.08e-06	0.000288	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CD80—malignant glioma	5.96e-06	0.000282	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—PIK3CB—malignant glioma	5.96e-06	0.000282	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PIK3CG—malignant glioma	5.95e-06	0.000282	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—APC—malignant glioma	5.95e-06	0.000282	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—PTGS2—malignant glioma	5.9e-06	0.00028	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—EGF—malignant glioma	5.88e-06	0.000278	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PTPN11—malignant glioma	5.84e-06	0.000277	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—BRAF—malignant glioma	5.59e-06	0.000265	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—AKT2—malignant glioma	5.44e-06	0.000258	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—EGFR—malignant glioma	5.42e-06	0.000257	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PIK3CD—malignant glioma	5.23e-06	0.000248	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—PIK3CA—malignant glioma	5.18e-06	0.000245	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—PTEN—malignant glioma	5.15e-06	0.000244	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—KRAS—malignant glioma	5.12e-06	0.000242	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—FGF2—malignant glioma	5.01e-06	0.000237	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—PIK3CA—malignant glioma	4.97e-06	0.000235	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—PIK3CA—malignant glioma	4.7e-06	0.000223	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—MDM2—malignant glioma	4.68e-06	0.000222	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—RAF1—malignant glioma	4.67e-06	0.000221	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—ERBB2—malignant glioma	4.62e-06	0.000219	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PIK3CB—malignant glioma	4.56e-06	0.000216	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CXCL8—malignant glioma	4.38e-06	0.000207	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—AKT1—malignant glioma	4.23e-06	0.0002	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CASP3—malignant glioma	4.19e-06	0.000198	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—IL2—malignant glioma	4.19e-06	0.000198	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—AKT1—malignant glioma	4.06e-06	0.000192	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—MMP9—malignant glioma	3.96e-06	0.000188	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PTEN—malignant glioma	3.94e-06	0.000186	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—AKT1—malignant glioma	3.84e-06	0.000182	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—PIK3CA—malignant glioma	3.63e-06	0.000172	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—VEGFA—malignant glioma	3.56e-06	0.000168	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—STAT3—malignant glioma	3.52e-06	0.000167	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—MYC—malignant glioma	3.27e-06	0.000155	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—EGFR—malignant glioma	3.2e-06	0.000152	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—KRAS—malignant glioma	3.02e-06	0.000143	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—AKT1—malignant glioma	2.97e-06	0.000141	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PIK3CA—malignant glioma	2.78e-06	0.000132	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—TP53—malignant glioma	2.69e-06	0.000127	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—AKT1—malignant glioma	2.27e-06	0.000107	CbGpPWpGaD
